Literature DB >> 25054002

Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes.

Minoru Tomizawa1, Yuji Kawanabe2, Fuminobu Shinozaki3, Sumihiko Sato2, Yasufumi Motoyoshi4, Takao Sugiyama5, Shigenori Yamamoto6, Makoto Sueishi5.   

Abstract

The aim of the present study was to reveal the metabolic disorders most commonly associated with nonalcoholic fatty liver disease (NAFLD). Triglyceride (TG), high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), blood glucose (BG) and hemoglobin A1c (HbA1c) were analyzed. NAFLD was diagnosed using abdominal ultrasound (US), and TG, HDL, LDL, BG and HbA1c were immediately collected on the same day and subjected to multivariate regression analysis. Stepwise analysis was performed to select the variables that were closely associated with NAFLD. The patients who were positive for the hepatitis B antigen and hepatitis C antibody were excluded from the study. Additionally, the patients who were prescribed prednisolone or methotrexate were excluded from the study as these agents may cause NAFLD or liver toxicity. The study included 168 and 125 patients with and without NAFLD, respectively. TG, BG and HbA1c were strongly correlated with NAFLD. Among these parameters, TG was the strongest predictor of NAFLD (χ2=9.89, P=0.0017). TG was the parameter that was most strongly associated with NAFLD. In conclusion, elevated TG was a marker of NAFLD.

Entities:  

Keywords:  blood glucose; hemoglobin A1c; multivariate regression analysis; receiver operating characteristics

Year:  2014        PMID: 25054002      PMCID: PMC4106613          DOI: 10.3892/br.2014.309

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  26 in total

1.  Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader; Gianfranco Pagano
Journal:  Ann Med       Date:  2010-11-02       Impact factor: 4.709

Review 2.  Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: a meta-analysis of clinical trials.

Authors:  Nabeel Khan; Ali M Abbas; Naree Whang; Luis A Balart; Lydia A Bazzano; Tanika N Kelly
Journal:  Inflamm Bowel Dis       Date:  2011-07-12       Impact factor: 5.325

3.  Exposure to a high total dosage of glucocorticoids produces non-alcoholic steatohepatits.

Authors:  Toshiharu Matsumoto; Shigetaka Yamasaki; Atsushi Arakawa; Keiko Abe; Hiroshi Abe; Kazuyoshi Kon; Shigeto Kobayashi; Yoshinari Takasaki
Journal:  Pathol Int       Date:  2007-06       Impact factor: 2.534

4.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

Review 5.  Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods.

Authors:  D Festi; R Schiumerini; L Marzi; A R Di Biase; D Mandolesi; L Montrone; E Scaioli; G Bonato; G Marchesini-Reggiani; A Colecchia
Journal:  Aliment Pharmacol Ther       Date:  2012-12-20       Impact factor: 8.171

6.  Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study.

Authors:  Teruki Miyake; Teru Kumagi; Masashi Hirooka; Shinya Furukawa; Mitsuhito Koizumi; Yoshio Tokumoto; Teruhisa Ueda; Shin Yamamoto; Masanori Abe; Kohichiro Kitai; Yoichi Hiasa; Bunzo Matsuura; Morikazu Onji
Journal:  J Gastroenterol       Date:  2012-08-31       Impact factor: 7.527

7.  Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

Authors:  Giorgio Bedogni; Lucia Miglioli; Flora Masutti; Claudio Tiribelli; Giulio Marchesini; Stefano Bellentani
Journal:  Hepatology       Date:  2005-07       Impact factor: 17.425

8.  A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial.

Authors:  Austin Nelson; Dawn M Torres; Ana E Morgan; Christopher Fincke; Stephen A Harrison
Journal:  J Clin Gastroenterol       Date:  2009 Nov-Dec       Impact factor: 3.062

9.  Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients.

Authors:  Takashi Nakahara; Hideyuki Hyogo; Masato Yoneda; Yoshio Sumida; Yuichiro Eguchi; Hideki Fujii; Masafumi Ono; Takumi Kawaguchi; Kento Imajo; Hiroshi Aikata; Saiyu Tanaka; Kazuyuki Kanemasa; Kazuma Fujimoto; Keizo Anzai; Toshiji Saibara; Michio Sata; Atushi Nakajima; Yoshito Itoh; Kazuaki Chayama; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2013-11-26       Impact factor: 7.527

Review 10.  Hepatic function and the cardiometabolic syndrome.

Authors:  Nicolas Wiernsperger
Journal:  Diabetes Metab Syndr Obes       Date:  2013-10-10       Impact factor: 3.168

View more
  34 in total

1.  Exploring the relationship between nonalcoholic fatty liver disease and pancreatic cancer by computed tomographic survey: comment.

Authors:  Shih-Wei Lai
Journal:  Intern Emerg Med       Date:  2018-10-11       Impact factor: 3.397

2.  Cathepsin B deficiency ameliorates liver lipid deposition, inflammatory cell infiltration, and fibrosis after diet-induced nonalcoholic steatohepatitis.

Authors:  Wenqian Fang; Zhiyong Deng; Feriel Benadjaoud; Chongzhe Yang; Guo-Ping Shi
Journal:  Transl Res       Date:  2020-05-11       Impact factor: 7.012

3.  Interval increase in the prevalence of symptomatic cholelithiasis-associated non-alcoholic fatty liver disease over a ten-year period in an Asian population.

Authors:  Kevin Beng Chin Khaw; Rachel Huiyi Choi; Juinn Huar Kam; Bibhas Chakraborty; Pierce Kah Hoe Chow
Journal:  Singapore Med J       Date:  2016-12-20       Impact factor: 1.858

4.  Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.

Authors:  Nima Motamed; Masoudreza Sohrabi; Hossein Ajdarkosh; Gholamreza Hemmasi; Mansooreh Maadi; Fatemeh Sima Sayeedian; Reza Pirzad; Khadijeh Abedi; Sivil Aghapour; Mojtaba Fallahnezhad; Farhad Zamani
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

5.  Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus.

Authors:  Mojtaba Malek; Mohammad E Khamseh; Haleh Chehrehgosha; Sohrab Nobarani; Fariba Alaei-Shahmiri
Journal:  Endocrine       Date:  2021-08-05       Impact factor: 3.633

6.  Association between colon diverticula and hemoglobin, triglyceride and uric acid levels.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Rumiko Hasegawa; Yoshinori Shirai; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Exp Ther Med       Date:  2015-10-15       Impact factor: 2.447

7.  The association between obstructive sleep apnea and non-alcoholic steatohepatitis: a retrospective nationwide inpatient sample analysis.

Authors:  Anas Renno; Yousef Abdel-Aziz; Yaseen Alastal; Sadik Khuder; Syed Hasan; Ragheb Assaly; Ali Nawras
Journal:  Clin Exp Hepatol       Date:  2021-03-25

8.  Mean and visit-to-visit variability of glycated hemoglobin, and the risk of non-alcoholic fatty liver disease.

Authors:  Jee Hee Yoo; Mira Kang; Gyuri Kim; Kyu Yeon Hur; Jae Hyeon Kim; Dong Hyun Sinn; Sang-Man Jin
Journal:  J Diabetes Investig       Date:  2020-12-05       Impact factor: 4.232

9.  Hepatic steatosis depresses alpha-1-antitrypsin levels in human and rat acute pancreatitis.

Authors:  Qian Wang; Jianjun Du; Pengfei Yu; Bin Bai; Zhanwei Zhao; Shiqi Wang; Junjie Zhu; Quanxin Feng; Yun Gao; Qingchuan Zhao; Chaoxu Liu
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

10.  Increased Hepatic Fatty Acids Uptake and Oxidation by LRPPRC-Driven Oxidative Phosphorylation Reduces Blood Lipid Levels.

Authors:  Shi Lei; Run-Zhu Sun; Di Wang; Mei-Zhen Gong; Xiang-Ping Su; Fei Yi; Zheng-Wu Peng
Journal:  Front Physiol       Date:  2016-07-12       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.